Myhanh T Nguyen, MD
Family Practice · Sunnyvale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 2
Offices
2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Nguyen’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G61875 · Current
Licensed to practise in California · since 1987 · expires 2027-06-30 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$24,621
Medicare paid this office $24,621 for 194 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (30+ min) | 105 | $9,494 | $90 |
| New patient visit (45+ min) | 42 | $5,609 | $134 |
| Return visit (30+ min) | 30 | $3,332 | $107 |
Who their Medicare patients are
194 Original Medicare patients in 2024. Average age 73 · Women 57% · Health risk score 0.60. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 53% · Coronary heart disease 18% · Diabetes 16% · Cancer 14% · Chronic kidney disease 10% · Atrial fibrillation 10% · Depression 10%.
The office billed $89,299, Medicare allowed $34,367 and paid $24,621; for 241 services of 20 kinds; $3,848 of it was for drugs given in the office and $20,772 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 194 | 241 | 73 | 0.60 | $89,299 | $24,621 |
| 2023 | 151 | 206 | 73 | 0.55 | $65,193 | $20,564 |
| 2022 | 89 | 119 | 72 | 0.53 | $36,791 | $12,638 |
| 2020 | 36 | 43 | 71 | 0.58 | $10,328 | $1,716 |
| 2019 | 48 | 69 | 70 | 0.74 | $12,163 | $4,607 |
| 2018 | 20 | 45 | 72 | 0.98 | $3,821 | $2,470 |
| 2017 | 12 | 24 | 71 | 0.56 | $1,341 | $1,115 |
| 2013 | 44 | 84 | 72 | 0.49 | $5,604 | $2,274 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 98 | $10,279 | $102 |
| Long return visit (40+ min) | 14 | $1,611 | $115 |
| New patient visit (30+ min) | 14 | $1,197 | $85 |
| Short return visit (20+ min) | 13 | $836 | $60 |
| Administration of pneumococcal vaccine | 12 | $421 | $35 |
2022: 3 services
| Return visit (30+ min) | 49 | $5,066 | $103 |
| Long return visit (40+ min) | 16 | $2,443 | $153 |
| Short return visit (20+ min) | 21 | $1,490 | $71 |
2020: 2 services
| Return visit (30+ min) | 15 | $734 | $49 |
| Short return visit (20+ min) | 20 | $313 | $16 |
2019: 2 services
| Short return visit (20+ min) | 22 | $1,439 | $65 |
| Return visit (30+ min) | 12 | $1,077 | $90 |
2013: 2 services
| Administration of vaccine | 30 | $555 | $18 |
| Administration of vaccine, each additional vaccine | 15 | $210 | $11 |
Drugs they prescribed that Part D paid
$16,593
Pharmacies billed $16,593 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
182 generic and fewer than 11 brand-name prescriptions · $16,593 in drug cost · 59 antibiotic prescriptions to 58 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atovaquone-Proguanil | 115 | $7,437 | $64 |
| Typhim Vi | 34 | $5,724 | $168 |
| Acetazolamide | 24 | $228 | $9 |
| Azithromycin | 53 | $193 | $4 |
Year by year
| 2024 | 268 | 176 | None | None | $16,593 |
| 2023 | 259 | 156 | 0% (0) | 36% | $17,797 |
| 2022 | 163 | 88 | None | 33% | $10,381 |
| 2021 | 12 | None | 0% (0) | None | $359 |
| 2020 | 63 | 36 | 0% (0) | 21% | $2,284 |
| 2019 | 239 | 130 | 0% (0) | 23% | $9,997 |
| 2018 | 209 | 113 | 0% (0) | 22% | $8,090 |
| 2017 | 196 | 97 | None | 16% | $6,648 |
| 2016 | 117 | 67 | None | 24% | $3,967 |
| 2015 | 111 | 50 | None | 35% | $4,609 |
| 2014 | 160 | 70 | 0% (0) | 37% | $8,094 |
| 2013 | 73 | 42 | None | 29% | $4,532 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Typhim Vi | 49 | $7,191 | $147 |
| Atovaquone-Proguanil | 85 | $7,163 | $84 |
| Vaqta | 11 | $1,640 | $149 |
| Azithromycin | 68 | $251 | $4 |
| Acetazolamide | 26 | $216 | $8 |
2022: 3 drugs
| Atovaquone-Proguanil | 46 | $5,083 | $111 |
| Typhim Vi | 20 | $2,694 | $135 |
| Azithromycin | 64 | $261 | $4 |
2020: 2 drugs
| Atovaquone-Proguanil | 17 | $1,113 | $65 |
| Azithromycin | 28 | $167 | $6 |
2019: 3 drugs
| Atovaquone-Proguanil | 78 | $6,187 | $79 |
| Azithromycin | 112 | $676 | $6 |
| Acetazolamide | 15 | $366 | $24 |
2018: 2 drugs
| Atovaquone-Proguanil | 80 | $5,520 | $69 |
| Azithromycin | 86 | $520 | $6 |
2017: 3 drugs
| Atovaquone-Proguanil | 66 | $4,971 | $75 |
| Azithromycin | 85 | $489 | $6 |
| Acetazolamide | 13 | $218 | $17 |
2016: 2 drugs
| Atovaquone-Proguanil | 31 | $2,010 | $65 |
| Azithromycin | 56 | $367 | $7 |
2015: 3 drugs
| Atovaquone-Proguanil | 24 | $1,705 | $71 |
| Azithromycin | 38 | $217 | $6 |
| Acetazolamide | 11 | $201 | $18 |
2014: 3 drugs
| Atovaquone-Proguanil | 27 | $2,443 | $90 |
| Azithromycin | 38 | $310 | $8 |
| Latanoprost | 21 | $272 | $13 |
2013: 2 drugs
| Atovaquone-Proguanil | 18 | $1,858 | $103 |
| Azithromycin | 29 | $291 | $10 |
Money from drug and device companies
$125 in 2025
A payment is not proof that care is biased.
| E.R. Squibb & Sons L.L.C. | None | $125 | 1 payment
|
See the published payment
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-10 | None | $125 |
Professional record
- NPI
- 1518067396
- Licence
- CA G61875California G61875: Current · expires 2027-06-30
- Trained
- University of California, San Francisco School of Medicine, 1986
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2083X0100X (2083X0100X); Family medicine (207Q00000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-09-22
- NPI last updated
- 2011-12-13
This is when the NPI record was last certified, not a medical board exam.